Coromandel International Ltd.
COROMANDELCommodities filings
We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.
Earnings calls
17 transcript(s)/analyst meet(s) served; 0 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 17 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20220804 | 2022-06-30 | yes | |
| TRANSCRIPT | 20221111 | 2022-09-30 | yes | |
| TRANSCRIPT | 20230213 | 2022-12-31 | yes | |
| TRANSCRIPT | 20230522 | 2023-03-31 | yes | |
| TRANSCRIPT | 20230803 | 2023-06-30 | yes | |
| TRANSCRIPT | 20231103 | 2023-09-30 | yes | |
| TRANSCRIPT | 20240206 | 2023-12-31 | yes | |
| TRANSCRIPT | 20240503 | 2024-03-31 | yes | |
| TRANSCRIPT | 20240814 | 2024-06-30 | yes | |
| TRANSCRIPT | 20241104 | 2024-09-30 | yes | |
| TRANSCRIPT | 20250206 | 2024-12-31 | yes | |
| TRANSCRIPT | 20250509 | 2025-03-31 | yes | |
| TRANSCRIPT | 20250801 | 2025-06-30 | yes | |
| TRANSCRIPT | 20251107 | 2025-09-30 | yes | |
| TRANSCRIPT | 20260209 | 2025-12-31 | yes | |
| TRANSCRIPT | 20260515 | 2026-03-31 | yes | |
| TRANSCRIPT | 20260731 | 2026-06-30 | yes |
COROMANDEL
files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.
Identity
| Statement division | general |
| Scope served | consolidated |
| Panels on this page | 4 |
Market
No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.
| Last close | 1,942.50 |
| 52-week range | 1745.6 – 2408.2 |
| Return 1M | 1.51% |
| Return 3M | -2.89% |
| Return 1Y | -12.92% |
| Return 3Y | 74.25% |
| Return 5Y | 140.59% |
| Market capitalisation | not shown — we could not confirm it |
| Shares outstanding | not shown — we could not confirm it |
| P/E | not shown — we could not confirm it |
| P/B | not shown — we could not confirm it |
| EV/EBITDA | not shown — we could not confirm it |
Latest quarter filed — period ending 2026-06-30
In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.
| Revenue from operations | 8,165.00 |
| Other income | 50.00 |
| Total income | 8,215.00 |
| Cost of materials consumed | 4,615.00 |
| Purchases of stock-in-trade | 2,667.00 |
| Changes in inventories | -1,100.00 |
| Employee benefit expense | 301.00 |
| Finance costs | 89.00 |
Ownership — 2026-06-30, and the change from 2026-03-31
| Holder | Per cent | Change |
|---|---|---|
| promoter and promoter group | 0.56 | 0.00 |
| institutions foreign | 0.12 | -0.02 |
| institutions domestic | 0.20 | 0.02 |
| mutual funds | 0.15 | 0.01 |
| public | 0.43 | 0.00 |
Documents on file
| Class | Most recent | On file |
|---|---|---|
| TRANSCRIPT | 2026-06-30 | 17 |
Financial statements
Filed results, consolidated, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.
Quarterly results, as filed
| Line | 2022-03-31 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 4,227.00 | 10,113.00 | 8,310.00 | 5,476.00 | 5,693.00 | 6,988.00 | 5,464.00 | 3,913.00 | 4,729.00 | 7,433.00 | 6,935.00 | 7,042.00 | 9,654.00 | 8,779.00 | 60.00 | 8,165.00 |
| Other income | 77.00 | 31.00 | 40.00 | 47.00 | 44.00 | 45.00 | 59.00 | 84.00 | 54.00 | 65.00 | 114.00 | 84.00 | 116.00 | 83.00 | 1.00 | 50.00 |
| Total income | 4,304.00 | 10,144.00 | 8,349.00 | 5,523.00 | 5,738.00 | 7,033.00 | 5,523.00 | 3,996.00 | 4,783.00 | 7,498.00 | 7,049.00 | 7,126.00 | 9,771.00 | 8,863.00 | 61.00 | 8,215.00 |
| Cost of materials consumed | 3,073.00 | 5,932.00 | 5,363.00 | 3,562.00 | 3,971.00 | 3,095.00 | 3,592.00 | 2,870.00 | 2,983.00 | 3,372.00 | 3,360.00 | 3,567.00 | 4,717.00 | 4,795.00 | 42.00 | 4,615.00 |
| Purchases of stock-in-trade | 104.00 | 1,650.00 | 1,533.00 | 403.00 | 1,304.00 | 496.00 | 1,124.00 | 297.00 | 1,085.00 | 1,137.00 | 2,103.00 | 2,347.00 | 1,797.00 | 2,886.00 | 8.00 | 2,667.00 |
| Changes in inventories | -35.00 | 646.00 | -204.00 | 271.00 | -1,056.00 | 1,527.00 | -391.00 | -347.00 | -586.00 | 1,058.00 | -165.00 | -675.00 | 850.00 | -933.00 | -7.00 | -1,100.00 |
| Employee benefit expense | 158.00 | 170.00 | 167.00 | 164.00 | 164.00 | 177.00 | 185.00 | 171.00 | 182.00 | 188.00 | 205.00 | 225.00 | 265.00 | 286.00 | 3.00 | 301.00 |
| Finance costs | 21.00 | 54.00 | 57.00 | 52.00 | 41.00 | 46.00 | 38.00 | 62.00 | 57.00 | 66.00 | 73.00 | 68.00 | 102.00 | 84.00 | 1.00 | 89.00 |
| Depreciation and amortisation | 45.00 | 46.00 | 47.00 | 45.00 | 48.00 | 54.00 | 64.00 | 63.00 | 65.00 | 69.00 | 71.00 | 121.00 | 102.00 | 147.00 | 2.00 | 203.00 |
| Other expenses | 548.00 | 658.00 | 670.00 | 672.00 | 601.00 | 634.00 | 596.00 | 649.00 | 560.00 | 703.00 | 710.00 | 796.00 | 879.00 | 946.00 | 9.00 | 926.00 |
| Total expenses | 3,914.00 | 9,156.00 | 7,633.00 | 5,170.00 | 5,073.00 | 6,030.00 | 5,208.00 | 3,764.00 | 4,346.00 | 6,593.00 | 6,357.00 | 6,449.00 | 8,711.00 | 8,210.00 | 58.00 | 7,701.00 |
| Profit before exceptional items and tax | 390.00 | 988.00 | 716.00 | 353.00 | 665.00 | 1,003.00 | 315.00 | 232.00 | 437.00 | 905.00 | 692.00 | 677.00 | 1,059.00 | 653.00 | 3.00 | 514.00 |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00 | 0.00 |
| Profit before tax | 390.00 | 988.00 | 716.00 | 353.00 | 665.00 | 1,003.00 | 315.00 | 232.00 | 437.00 | 905.00 | 692.00 | 677.00 | 1,059.00 | 653.00 | 2.00 | 514.00 |
| Current tax | 92.00 | 247.00 | 180.00 | 90.00 | 170.00 | 244.00 | 73.00 | 59.00 | 114.00 | 232.00 | 180.00 | 177.00 | 282.00 | 187.00 | 1.00 | 111.00 |
| Deferred tax | 7.00 | 1.00 | -0.00 | -0.00 | -3.00 | 1.00 | 5.00 | -1.00 | -2.00 | 0.00 | -5.00 | -2.00 | -16.00 | -23.00 | 0.00 | 22.00 |
| Tax expense | 99.00 | 248.00 | 179.00 | 90.00 | 167.00 | 245.00 | 78.00 | 58.00 | 113.00 | 233.00 | 175.00 | 176.00 | 266.00 | 164.00 | 1.00 | 132.00 |
| Profit for the period | 290.00 | 741.00 | 527.00 | 246.00 | 494.00 | 755.00 | 228.00 | 164.00 | 309.00 | 659.00 | 508.00 | 502.00 | 793.00 | 488.00 | 1.00 | 382.00 |
| Profit attributable to owners | 290.00 | 741.00 | 527.00 | 246.00 | 494.00 | 757.00 | 231.00 | 160.00 | 311.00 | 663.00 | 512.00 | 505.00 | 805.00 | 506.00 | 1.00 | — |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.00 | -3.00 | 4.00 | -2.00 | -5.00 | -4.00 | -3.00 | -12.00 | -17.00 | -0.00 | — |
| Other comprehensive income | 18.00 | -12.00 | 8.00 | -133.00 | 2.00 | 60.00 | -4.00 | -9.00 | 1.00 | -1.00 | -2.00 | -1.00 | 28.00 | 1.00 | 0.00 | -12.00 |
| Total comprehensive income | 308.00 | 728.00 | 535.00 | 113.00 | 496.00 | 814.00 | 224.00 | 155.00 | 310.00 | 658.00 | 506.00 | 501.00 | 821.00 | 490.00 | 2.00 | 370.00 |
| Earnings per share, basic | 9.87 | 25.21 | 17.92 | 8.38 | 16.80 | 25.72 | 7.84 | 5.45 | 10.57 | 22.57 | 17.39 | 17.15 | 27.34 | 17.17 | 4.75 | 12.93 |
| Earnings per share, diluted | 9.86 | 25.15 | 17.89 | 8.37 | 16.78 | 25.69 | 7.83 | 5.45 | 10.56 | 22.53 | 17.36 | 17.12 | 27.30 | 17.14 | 4.75 | 12.92 |
Annual results, as filed
| Line | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 13,225.00 | 13,137.00 | 14,213.00 | 19,111.00 | 29,628.00 | 22,058.00 | 315.00 |
| Other income | 37.00 | 40.00 | 44.00 | 144.00 | 171.00 | 231.00 | 3.00 |
| Total income | 13,262.00 | 13,177.00 | 14,257.00 | 19,255.00 | 29,799.00 | 22,290.00 | 318.00 |
| Cost of materials consumed | 7,965.00 | 7,502.00 | 6,979.00 | 11,897.00 | 19,556.00 | 13,528.00 | 172.00 |
| Purchases of stock-in-trade | 2,159.00 | 1,350.00 | 2,169.00 | 2,435.00 | 4,664.00 | 3,221.00 | 79.00 |
| Changes in inventories | -785.00 | 204.00 | 539.00 | -115.00 | -748.00 | -266.00 | -14.00 |
| Employee benefit expense | 411.00 | 461.00 | 539.00 | 587.00 | 657.00 | 698.00 | 10.00 |
| Finance costs | 251.00 | 235.00 | 106.00 | 75.00 | 190.00 | 187.00 | 3.00 |
| Depreciation and amortisation | 114.00 | 158.00 | 173.00 | 173.00 | 182.00 | 229.00 | 5.00 |
| Other expenses | 2,031.00 | 1,889.00 | 1,971.00 | 2,157.00 | 2,573.00 | 2,480.00 | 35.00 |
| Total expenses | 12,146.00 | 11,799.00 | 12,476.00 | 17,209.00 | 27,074.00 | 20,075.00 | 291.00 |
| Profit before exceptional items and tax | 1,116.00 | 1,378.00 | 1,781.00 | 2,046.00 | 2,725.00 | 2,215.00 | 27.00 |
| Exceptional items | -24.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00 |
| Profit before tax | 1,092.00 | 1,378.00 | 1,781.00 | 2,046.00 | 2,725.00 | 2,215.00 | 26.00 |
| Current tax | 387.00 | 369.00 | 460.00 | 519.00 | 692.00 | 545.00 | 7.00 |
| Deferred tax | -15.00 | -55.00 | -3.00 | 3.00 | -4.00 | 2.00 | -0.00 |
| Tax expense | 372.00 | 313.00 | 457.00 | 521.00 | 688.00 | 548.00 | 7.00 |
| Profit for the period | 720.00 | 1,065.00 | 1,329.00 | 1,528.00 | 2,013.00 | 1,641.00 | 19.00 |
| Profit attributable to owners | 720.00 | 1,065.00 | 1,329.00 | 1,528.00 | 2,013.00 | 1,642.00 | 20.00 |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.00 | -1.00 |
| Other comprehensive income | -41.00 | -1.00 | 13.00 | 24.00 | -138.00 | 49.00 | 1.00 |
| Total comprehensive income | 680.00 | 1,064.00 | 1,342.00 | 1,553.00 | 1,875.00 | 1,689.00 | 20.00 |
| Earnings per share, basic | 24.64 | 36.40 | 45.34 | 52.09 | 68.51 | 55.81 | 66.41 |
| Earnings per share, diluted | 24.60 | 36.31 | 45.22 | 51.98 | 68.38 | 55.75 | 66.31 |
Balance sheet, as filed
| Line | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|
| Total assets | 16,901.00 | 14,235.00 | 14,389.00 | 15,852.00 | 16,973.00 | 24,736.00 | 245.00 |
| Non-current assets | 2,874.00 | 3,991.00 | 3,699.00 | 3,728.00 | 4,816.00 | 7,751.00 | 87.00 |
| Current assets | 14,027.00 | 10,244.00 | 10,690.00 | 12,123.00 | 12,157.00 | 16,985.00 | 158.00 |
| Property, plant and equipment | 2,086.00 | 2,191.00 | 2,700.00 | 2,789.00 | 3,074.00 | 3,155.00 | 44.00 |
| Capital work-in-progress | 197.00 | 376.00 | 248.00 | 205.00 | 162.00 | 938.00 | 3.00 |
| Goodwill | 0.00 | 0.00 | 282.00 | 285.00 | 285.00 | 670.00 | 6.00 |
| Other intangible assets | 10.00 | 9.00 | 40.00 | 38.00 | 32.00 | 1,047.00 | 11.00 |
| Inventories | 4,992.00 | 4,416.00 | 3,375.00 | 4,612.00 | 3,784.00 | 5,573.00 | 72.00 |
| Trade receivables | 830.00 | 589.00 | 1,194.00 | 1,394.00 | 1,914.00 | 5,372.00 | 21.00 |
| Cash and cash equivalents | 81.00 | 1,394.00 | 1,217.00 | 1,125.00 | 697.00 | 348.00 | 4.00 |
| Total equity and liabilities | 16,901.00 | 14,235.00 | 14,389.00 | 15,852.00 | 16,973.00 | 24,736.00 | 245.00 |
| Equity | 7,425.00 | 7,908.00 | 9,090.00 | 9,447.00 | 10,235.00 | 12,684.00 | 131.00 |
| Equity share capital | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 0.00 |
| Other equity | 7,396.00 | 7,878.00 | 9,031.00 | 9,390.00 | 10,126.00 | 12,149.00 | 125.00 |
| Total liabilities | 9,476.00 | 6,327.00 | 5,299.00 | 6,405.00 | 6,739.00 | 12,052.00 | 114.00 |
| Non-current liabilities | 450.00 | 471.00 | 507.00 | 541.00 | 607.00 | 918.00 | 9.00 |
| Current liabilities | 9,025.00 | 5,856.00 | 4,793.00 | 5,864.00 | 6,132.00 | 11,134.00 | 105.00 |
| Borrowings, non-current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 145.00 | 1.00 |
| Borrowings, current | 1,279.00 | 5.00 | 11.00 | 52.00 | 74.00 | 738.00 | 8.00 |
| Trade payables | 7,122.00 | 5,314.00 | 4,213.00 | 5,361.00 | 5,534.00 | 9,411.00 | 38.00 |
Cash flow, as filed
| Line | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 | 2024-03-31 | 2024-09-30 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | 1,054.00 | -1,918.00 | 1,615.00 | 1,206.00 | 1,358.00 | 930.00 | 1,971.00 | 16.00 |
| Net cash from investing activities | -598.00 | 270.00 | -385.00 | -1,114.00 | -1,264.00 | -1,042.00 | -1,537.00 | -6.00 |
| Net cash from financing activities | -443.00 | 1,022.00 | -543.00 | -270.00 | -363.00 | -317.00 | -342.00 | -8.00 |
| Purchase of property, plant and equipment | 278.00 | 234.00 | 605.00 | 369.00 | 527.00 | 347.00 | 708.00 | 15.00 |
| Net increase in cash | 14.00 | -625.00 | 688.00 | -177.00 | -269.00 | -428.00 | 94.00 | 2.00 |
| con:CFO.BEFORE_TAX | 1,537.00 | -1,641.00 | 2,319.00 | 1,539.00 | 1,977.00 | 1,204.00 | 2,252.00 | 23.00 |
| con:INTEREST_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INTEREST_PAID.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:DIVIDENDS_RECEIVED.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:TAX_PAID.OPERATING | 483.00 | 277.00 | 704.00 | 333.00 | 619.00 | 274.00 | 280.00 | 7.00 |
| con:CF_OTHER.OPERATING | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:INVESTMENTS_PURCHASED | 0.00 | 183.00 | 46.00 | 0.00 | 3.00 | 24.00 | 0.00 | 0.00 |
| con:INVESTMENTS_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:PPE_DISPOSALS | 1.00 | 19.00 | 16.00 | 10.00 | 9.00 | 3.00 | 2.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.SUBSIDIARIES_ACQUIRED | 0.00 | 0.00 | 0.00 | 220.00 | 0.00 | 2.00 | 809.00 | 8.00 |
| con:CF_INVESTING.JV_SOLD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| con:CF_INVESTING.JV_ACQUIRED | 0.00 | 0.00 | 157.00 | 0.00 | 220.00 | 0.00 | 0.00 | 0.00 |
Who owns it
The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.
| Holder | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter and promoter group | 57.41 | 57.40 | 57.33 | 57.33 | 57.32 | 57.31 | 57.17 | 56.97 | 56.96 | 56.90 | 0.57 | 0.57 | 0.56 | 0.56 |
| Domestic institutions | 18.90 | 20.63 | 21.14 | 20.25 | 20.67 | 20.82 | 21.26 | 21.02 | 18.98 | 15.86 | 0.16 | 0.17 | 0.18 | 0.20 |
| Mutual funds | — | — | — | — | — | — | — | — | — | 13.12 | 0.13 | 0.13 | 0.14 | 0.15 |
| Insurance companies | 2.58 | 2.89 | 3.24 | 3.10 | 4.13 | 4.57 | 3.95 | 3.90 | 3.26 | 1.97 | 0.02 | 0.03 | 0.03 | 0.04 |
| Foreign institutions | 9.40 | 7.56 | 7.19 | 7.71 | 7.34 | 7.52 | 7.79 | 8.33 | 10.61 | 14.29 | 0.15 | 0.14 | 0.13 | 0.12 |
| Public | 42.59 | 42.60 | 42.67 | 42.67 | 42.68 | 42.69 | 42.83 | 43.03 | 43.04 | 43.00 | 0.43 | 0.43 | 0.43 | 0.43 |
| Non-institutional | 14.29 | 14.41 | 14.34 | 14.71 | 14.67 | 14.35 | 13.78 | 13.68 | 13.45 | 12.85 | 0.13 | 0.13 | 0.12 | 0.12 |
| Shares outstanding | 294013749 | 294043449 | 294393529 | 294403049 | 294442969 | 294500579 | 294531519 | 294622019 | 294636339 | 294837949 | 294921109 | 294995409 | 295014639 | 295016439 |
Related parties
Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.
| Counterparty | Relationship | Type | Amount in the period | Transactions |
|---|---|---|---|---|
| Coromandel Technology Limited | Subsidiary | Any other transaction | 1,506,608,000.00 | 2 |
| A M M Foundation | Promoter Group | Any other transaction, Purchase of fixed assets | 972,801,000.00 | 4 |
| Coromandel Chemicals Limited | Subsidiary | Any other transaction, Interest received, Sale of go | 790,040,000.00 | 4 |
| Baobab Mining and Chemicals Corporation (BMCC) | Associate | Advance, Any other transaction | 419,532,000.00 | 2 |
| Coromandel Provident Fund No. 1 | Employee Benefit Plan | Any other transaction | 233,745,000.00 | 1 |
| Parry Enterprises India Limited | Promoter Group | Any other transaction | 116,485,000.00 | 2 |
| Parry America Inc | Subsidiary | Any other transaction, Sale of goods or services | 79,637,000.00 | 2 |
| Jayashree Satagopan | Key Management Personnel - Chief F | Remuneration | 78,396,000.00 | 1 |
| Coromandel Superannuation Fund | Employee Benefit Plan | Any other transaction | 65,894,000.00 | 1 |
| Coromandel Gratuity Fund | Employee Benefit Plan | Any other transaction | 63,564,000.00 | 1 |
| Arun Alagappan | Key Management Personnel - Executi | Remuneration | 60,040,000.00 | 1 |
| E.I.D. Parry (India) Limited | Parent company | Any other transaction, Purchase of goods or services | 31,112,000.00 | 4 |
| Raghuram Devarakonda | Key Management Personnel - Executi | Remuneration | 29,418,000.00 | 1 |
| Sankarasubramanian | Key Management Personnel - Managin | Remuneration | 29,284,000.00 | 1 |
| Arun Vellayan | Key Management Personnel - Wholeti | Remuneration | 26,904,000.00 | 1 |
What management said
Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.
| Date | Quarter | Who spoke | |
|---|---|---|---|
| 2026-07-31 | Q1FY27 | Read the call | |
| 2026-05-15 | Q4FY26 | Read the call | |
| 2026-02-09 | Q3FY26 | Read the call | |
| 2025-11-07 | Q2FY26 | Read the call | |
| 2025-08-01 | Q1FY26 | COROMANDEL INTERNATIONAL LIMITED | Read the call |
| 2025-05-09 | Q4FY25 | Read the call | |
| 2025-02-06 | Q3FY25 | COROMANDEL INTERNATIONAL LIMITED | Read the call |
| 2024-11-04 | Q2FY25 | CHIEF, COROMANDEL INTERNATIONAL LIMITED, CORPORATE, EXECUTIVE, JAYASHREE, MANAGING, RAGHUR | Read the call |
| 2024-08-14 | Q1FY25 | COROMANDEL INTERNATIONAL | Read the call |
| 2024-05-03 | Q4FY24 | Read the call | |
| 2024-02-06 | Q3FY24 | Read the call | |
| 2023-11-03 | Q2FY24 | CHIEF, COROMANDEL INTERNATIONAL LIMITED, CORPORATE, EXECUTIVE, JAYASHREE, RAGHURAM | Read the call |
| 2023-08-03 | Q1FY24 | INTERNATIONAL LIMITED, LIMITED | Read the call |
| 2023-05-22 | Q4FY23 | COROMANDEL INTERNATIONAL LIMITED, DIRECTOR (NUTRIENT BUSINESS), COROMANDEL, OFFICER, COROM | Read the call |
| 2023-02-13 | Q3FY23 | - COROMANDEL INTERNATIONAL LIMITED | Read the call |
| 2022-11-11 | Q2FY23 | - COROMANDEL INTERNATIONAL LIMITED, COROMANDEL INTERNATIONAL LIMITED, MANAGING, SAMEER | Read the call |
| 2022-08-04 | Q1FY23 | COROMANDEL INTERNATIONAL LIMITED, MANAGING, OFFICER, COROMANDEL INTERNATIONAL LIMITED, SAM | Read the call |
What they said about it, quarter by quarter
| Topic | Q3FY23 | Q3FY24 | Q3FY25 | Q3FY26 | Q4FY23 | Q4FY24 | Q4FY25 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Capex | — | So the new capex that has been announced, the capex that has already happened is all through our own internal accrual. | As a strategy, we have decided to scale up the volume in the next 2 years to ensure that whenever the new plant comes up, we | But having said that, we are also expanding our other technicals whether it is Malathion capacity expansion or looking at new Strobilurin chemistries … | Major capital expenditure projects like the sulfuric acid plant and the desalinization plants are progressing well as per the schedule. | This has been also factored in the business plan and the capex for FY '25. | And sir, before I join the queue, last question, how is our CAPEX plan going on? | — |
| Capital allocation | — | — | The Board in its meeting held on 30th January 2025, has approved an interim dividend of Rs. | We have achieved what we said at the time of acquisition, we will do 300,000. | The board in its meeting held on 15th May, 2023 has recommended a final dividend of Rs. | And last one is our acquisition, which we did from E.I.D - Parry earlier, how that business is playing out? | The proposed acquisition will position Coromandel as one of the leading players in the Indian crop protection sector with a wide range of Technicals a… | It is more of a accounting between the acquisition value versus the holding value that gets amortized over the period. |
| Costs | See the sulfuric acid is more investment from the view point of securing the raw material. | The NBS rate for rabi Coromandel International Limited January 31, 2024 season underwent a steep downward revision, which coupled with the rising raw … | Overall, I would say the raw material prices remain reasonably stable and likely to remain stable in the fourth quarter with the easing of geopolitica… | On the agrochemical side, on the other hand, we do expect some benefits to come in on the import of intermediates and key raw materials, which we curr… | Our commercial teams have continued to ensure timely availability of raw materials to enable continuous production and the manufacturing plants by sta… | See, overall price is a function of global prices of input raw materials and commodity prices. | The Government has announced nutrient-based subsidy rates for 25-26, with the increase in P rate almost 42%, in line with increase in global DAP price… | Secondly, on the margins of the fertilizer business for the upcoming season, how should one look at it considering the very nominal increase in the su… |
| Debt and cash | — | The balance sheet of the company continues to be strong, and the company is currently focusing on tightly managing the working capital situation. | Focus on working capital improvements has helped in augmenting the cash position. | We have addressed the liquidity part by raising money through rights issue and reduced the interest burden, brought in the working capital discipline … | During the year the Company had elevated working capital requirements primarily due to the high raw material prices as well as the higher subsidy outs… | And fourthly, let's not forget the fact that some of our businesses are highly working capital intensive. | And working capital also, considering the pull it generates, I think we are able to leverage better on the sourcing part. | We also want to be conscious on working capital liquidity. |
| Demand | So given that there is a good demand for fertilizers, our production, our imports will be helpful in terms of meeting the farmer requirements. | Despite this, India has remained resilient, supported by robust domestic demand, strong public infrastructure investment and strengthening financial s… | On the industry side, fertilizer raw materials have been fairly stable, except for sulfur and sulfuric acid due to demand coming from China and Indone… | On the other hand, in the domestic B2C, there are a lot of in-licensed molecules -- we have a pipeline of 9 key registrations which are happening, and… | May 16,2023 The R&D and product registration teams are working closely on a rich pipeline of new and combination products to be launched in the coming… | And from an industry price increase, how do we see things because earlier there were -- I mean, in one of the calls earlier, we were saying it is also… | Recently, sulfur, sulfuric acid prices went up as a result of demand from China, Indonesia and Morocco. | Our additional capacity, which came up in Dahej during the year, was quite helpful to meet the additional demand. |
| Guidance | How much decline if at all if it happens can we anticipate or any further room to improve. | And the second question is, phosphoric acid, can you guide us how much capacity we are going to increase and how much inventory loss in this quarter? | Some of our key molecules have received good interest from the market, and we expect the situation to further improve in the coming periods. | But for the unseasonal rains we had, we expected much better growth. | We expect a 6% to 10% improvement in the manufacturing volumes even in the coming year and that should be possible. | So we used to give guidance earlier around Rs. | We expect the transaction closure and regulatory approvals to come through by Q2 of this year. | So, in view of the raw material inflation, what should be our margin guidance as far as EBITDA per ton is concerned for the whole year? |
| Margin | So, with that background, how do we see fertilizer demand for FY2024, that is first question, and since we are operating almost at full capacity, so w… | Lower volumes along with the low NBS rates and higher cost of raw material has impacted the business margin during the quarter. | Business also improved its margin structure - EBIT has improved by 8%, especially driven by domestic B2B and formulation segment. | So, sir, one, possibly the improvement of margins is because of the higher volumes and we would have achieved operating leverage out of our plants wit… | In Q4 97% of the stores were profitable as they focus on high margin products and operated with the negative working capital level. | Ma'am, first question is on fertilizer margin. | As far as profitability is concerned, the consolidated EBITDA for the quarter was Rs. | With the increased volume of operations, better absorption of fixed costs, improved efficiencies and market linked price, it turns profitable and it w… |
| People | Just wanted to get a sense on what is the post-tax cash payback that you are anticipating for this plant once it commercializes and how much time will… | — | Definitely, the capacity utilization may come down due to monocrotophos moving out, but we are repurposing these plants with new technicals and new pr… | Sir, also the backward integration plant, which is expected to start this quarter, what is the kind of utilization that we will plan to have during th… | So, we will be looking into all these options to maximize our capacity utilization. | Did I hear it right, you mentioned 20%, 25% utilization next year? | NACL is to get back in terms of capacity utilization. | But capacity utilization of the technical plants have improved significantly. |
| Pricing | So that has actually led to a bit of a pricing war if I want to use that terminology, and from our standpoint, the business has taken a pretty conscio… | Each of them has been given a certain percentage of PBT that they can broadly look at as they work through their MRPs, their cost structures and their… | So my suggestion would be, instead of specific products and pricing, let's look at the macro picture. | The second part possibly could be the price increase or is it because of the launch of newer products out of what we have announced in the start of th… | As the business case gets developed, we also look into the global trends in terms of pricing, capacities, existing new capacities that are coming up i… | We have been able to take price increases with the customers. | Now the end product prices on NPK fertilizers will get corrected as we move forward, besides DAP, to absorb this price increase. | So how do you see government response coming in, whether there can be another sort of a price increase rather subsidy increase, which sort of happened… |
| Revenue growth | Once we see some sort of stability in the market and the new products kicking in, we should see a growth of about 10%-12%, or so. | On the Crop Protection side, the Crop Protection business of the company reported a healthy volume growth of 21%, improving its performance in exports… | Primary sale of NPKs in Q3 stands at 11.4 lakh tons as against 9.4 lakh tons we had last year corresponding period, registering growth of 21%. | As I mentioned, domestic industry faced rough weather during this quarter and the growth was marginal. | As far as SSP is concerned, Q4 sales was at 1.9 lakh metric tons with the growth of 19% over the last year and on a full year basis SSP business clock… | And what are the top line growth you can expect in the non-subsidized business excluding Crop Protection? | This registers a growth of 28% for the quarter and 10% for the full year. | Overall, we can see a revenue growth of 20%-25% besides the capacity-driven growth in active ingredients which were mainly for the export market. |
What they said they would do
Sentences in which management set an expectation. Each names the speaker and the page of the transcript it came from.
| Date | Quarter | Who | What they said |
|---|---|---|---|
| 2022-11-11 | Q2FY23 | SAMEER | The northeast monsoon is expected to be normal and with good reservoir levels currently at 108% of last year, we expect the rabi season to be good. |
| 2023-05-22 | Q4FY23 | COROMANDEL INTERNATIONAL LIMITED | We expect a 6% to 10% improvement in the manufacturing volumes even in the coming year and that should be possible. |
| 2023-05-22 | Q4FY23 | COROMANDEL INTERNATIONAL LIMITED | We have a large chunk going into fertilizers and SSP and some amount that goes into bio products that is how the entire 2,000 crore is split into and we expect this cash outflow to happen over a period of couple of years as we place the orders as some of these projects are going to be 18 to 24 months in terms of time taken to complete the construction. |
| 2024-11-04 | Q2FY25 | COROMANDEL INTERNATIONAL LIMITED | This project is likely to be commissioned by March '26, and hopefully when this plant is ready, overall 60% to 70% of our captive acid requirements will be met internally, giving us a lot of operational flexibility and raw material security. |